Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helle D Zacho

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Nuclear Medicine Communications|January 19, 2017
Observer agreement of treatment responses on planar bone scintigraphy in prostate cancer patients: importance of the lesion assessment methodRandi F Fonager, Helle D Zacho, Signe Albertsen, et al.
Nuclear Medicine Communications|April 1, 2022
Observer experience and accuracy of 18F-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancerHelle D Zacho, Søren Ravn, June A Ejlersen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2019
<sup>68</sup>Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocolFabian Haupt, Lotte Dijkstra, Ian Alberts, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 29, 2017
Diagnostic test accuracy study of <sup>18</sup>F-sodium fluoride PET/CT, <sup>99m</sup>Tc-labelled diphosphonate SPECT/CT, and planar bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancerRandi F Fonager, Helle D Zacho, Niels C Langkilde, et al.
World Journal of Urology|June 14, 2019
<sup>68</sup>Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy studyLars J Petersen, Julie B Nielsen, Niels C Langkilde, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2018
Prospective comparison of <sup>68</sup>Ga-PSMA PET/CT, <sup>18</sup>F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancerHelle D Zacho, Julie B Nielsen, Ali Afshar-Oromieh, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 26, 2023
Deep learning based identification of bone scintigraphies containing metastatic bone disease fociAbdalla Ibrahim, Akshayaa Vaidyanathan, Sergey Primakov, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective StudyWolfgang Peter Fendler, Jeremie Calais, Martin Allen-Auerbach, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
European Urology|July 23, 2023
Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging TrialLoïc Djaïleb, Wesley R Armstrong, Daniel Thompson, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Nuclear Medicine Communications|January 19, 2017
Observer agreement of treatment responses on planar bone scintigraphy in prostate cancer patients: importance of the lesion assessment methodRandi F Fonager, Helle D Zacho, Signe Albertsen, et al.
Nuclear Medicine Communications|April 1, 2022
Observer experience and accuracy of 18F-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancerHelle D Zacho, Søren Ravn, June A Ejlersen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2019
<sup>68</sup>Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocolFabian Haupt, Lotte Dijkstra, Ian Alberts, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 29, 2017
Diagnostic test accuracy study of <sup>18</sup>F-sodium fluoride PET/CT, <sup>99m</sup>Tc-labelled diphosphonate SPECT/CT, and planar bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancerRandi F Fonager, Helle D Zacho, Niels C Langkilde, et al.
World Journal of Urology|June 14, 2019
<sup>68</sup>Ga-PSMA PET/CT compared with MRI/CT and diffusion-weighted MRI for primary lymph node staging prior to definitive radiotherapy in prostate cancer: a prospective diagnostic test accuracy studyLars J Petersen, Julie B Nielsen, Niels C Langkilde, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2018
Prospective comparison of <sup>68</sup>Ga-PSMA PET/CT, <sup>18</sup>F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancerHelle D Zacho, Julie B Nielsen, Ali Afshar-Oromieh, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 26, 2023
Deep learning based identification of bone scintigraphies containing metastatic bone disease fociAbdalla Ibrahim, Akshayaa Vaidyanathan, Sergey Primakov, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective StudyWolfgang Peter Fendler, Jeremie Calais, Martin Allen-Auerbach, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
European Urology|July 23, 2023
Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging TrialLoïc Djaïleb, Wesley R Armstrong, Daniel Thompson, et al.
Pageof 10